[Therapeutic principles in hyperkinetic syndromes].
Arzumanian
A M
AM
Stupa
M V
MV
D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy / Q000503:physiopathology / Q000523:psychology; D005145:Face; D005152:Facial Muscles / Q000503:physiopathology; D006801:Humans; D006948:Hyperkinesis / Q000188:drug therapy* / Q000503:physiopathology / Q000523:psychology; D008538:Meige Syndrome / Q000188:drug therapy / Q000503:physiopathology / Q000523:psychology; D009069:Movement Disorders / Q000188:drug therapy / Q000503:physiopathology / Q000523:psychology; D011603:Psychophysiology; D012074:Remission Induction; D013035:Spasm / Q000188:drug therapy / Q000503:physiopathology / Q000523:psychology; D013577:Syndrome
Printsipy terapii nekotorykh giperkineticheskikh sindromov.